OTCMKTS:LBTSF

Almirall Competitors

$15.15
0.00 (0.00 %)
(As of 04/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$15.15
Now: $15.15
$15.15
50-Day Range
$12.40
MA: $14.00
$15.20
52-Week Range
$14.00
Now: $15.15
$15.20
VolumeN/A
Average Volume1,433 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Almirall (OTCMKTS:LBTSF) Vs. DDXS, TNGN, ATTBF, ADTX, AGNPF, and CBDC

Should you be buying LBTSF stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Almirall, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), ADiTx Therapeutics (ADTX), Algernon Pharmaceuticals (AGNPF), and Apotheca Biosciences (CBDC).

(DDXS) (OTCMKTS:DDXS) and Almirall (OTCMKTS:LBTSF) are both health technology companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

Analyst Recommendations

This is a breakdown of current recommendations for (DDXS) and Almirall, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(DDXS)0000N/A
Almirall01102.50

Valuation & Earnings

This table compares (DDXS) and Almirall's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(DDXS)N/AN/AN/AN/AN/A
AlmirallN/AN/AN/AN/AN/A

Profitability

This table compares (DDXS) and Almirall's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(DDXS)N/AN/AN/A
AlmirallN/AN/AN/A

Summary

Almirall beats (DDXS) on 1 of the 1 factors compared between the two stocks.

Almirall (OTCMKTS:LBTSF) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Analyst Ratings

This is a summary of current recommendations and price targets for Almirall and (TNGN), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Almirall01102.50
(TNGN)0000N/A

Valuation and Earnings

This table compares Almirall and (TNGN)'s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AlmirallN/AN/AN/AN/AN/A
(TNGN)N/AN/AN/AN/AN/A

Profitability

This table compares Almirall and (TNGN)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AlmirallN/AN/AN/A
(TNGN)N/AN/AN/A

Summary

Almirall beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Almirall (OTCMKTS:LBTSF) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Analyst Ratings

This is a summary of current recommendations and price targets for Almirall and Abattis Bioceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Almirall01102.50
Abattis Bioceuticals0000N/A

Valuation and Earnings

This table compares Almirall and Abattis Bioceuticals' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AlmirallN/AN/AN/AN/AN/A
Abattis BioceuticalsN/AN/AN/AN/AN/A

Profitability

This table compares Almirall and Abattis Bioceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AlmirallN/AN/AN/A
Abattis BioceuticalsN/AN/AN/A

Summary

Almirall beats Abattis Bioceuticals on 1 of the 1 factors compared between the two stocks.

Almirall (OTCMKTS:LBTSF) and ADiTx Therapeutics (NASDAQ:ADTX) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Analyst Ratings

This is a summary of current recommendations and price targets for Almirall and ADiTx Therapeutics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Almirall01102.50
ADiTx Therapeutics00103.00

Valuation and Earnings

This table compares Almirall and ADiTx Therapeutics' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AlmirallN/AN/AN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/AN/AN/A

Profitability

This table compares Almirall and ADiTx Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AlmirallN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/A

Summary

ADiTx Therapeutics beats Almirall on 1 of the 1 factors compared between the two stocks.

Almirall (OTCMKTS:LBTSF) and Algernon Pharmaceuticals (OTCMKTS:AGNPF) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Profitability

This table compares Almirall and Algernon Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AlmirallN/AN/AN/A
Algernon PharmaceuticalsN/AN/AN/A

Valuation and Earnings

This table compares Almirall and Algernon Pharmaceuticals' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AlmirallN/AN/AN/AN/AN/A
Algernon PharmaceuticalsN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Almirall and Algernon Pharmaceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Almirall01102.50
Algernon Pharmaceuticals0000N/A

Summary

Almirall beats Algernon Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

Apotheca Biosciences (NASDAQ:CBDC) and Almirall (OTCMKTS:LBTSF) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership and dividends.

Profitability

This table compares Apotheca Biosciences and Almirall's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Apotheca BiosciencesN/AN/AN/A
AlmirallN/AN/AN/A

Valuation and Earnings

This table compares Apotheca Biosciences and Almirall's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apotheca BiosciencesN/AN/AN/AN/AN/A
AlmirallN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Apotheca Biosciences and Almirall, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Apotheca Biosciences0000N/A
Almirall01102.50

Summary

Almirall beats Apotheca Biosciences on 1 of the 1 factors compared between the two stocks.


Almirall Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00Gap Up
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.52flat$0.00N/A0.00
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.12flat$0.00N/A0.00
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.07flat$0.00N/A0.00Gap Up
ARNI
Arno Therapeutics
0.5$0.01flat$0.00N/A0.00Gap Up
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06flat$0.00N/A0.00
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.56flat$0.00N/A0.00
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52flat$0.00N/A0.00
BMEA
Biomea Fusion
0.0$16.79flat$0.00N/A0.00
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.18flat$0.00N/A0.00News Coverage
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.03flat$0.00N/A0.00Gap Up
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$23.20flat$0.00N/A0.00
CELZ
Creative Medical Technology
0.5$0.03flat$0.00N/A0.00
Cybin logo
CLXPF
Cybin
0.7$1.17flat$0.00N/A0.00News Coverage
Gap Up
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.01flat$0.00N/A0.00
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.14flat$0.00N/A0.00Gap Up
GB Sciences logo
GBLX
GB Sciences
0.5$0.05flat$0.00N/A0.00News Coverage
Genfit logo
GNFTF
Genfit
0.5$4.52flat$0.00N/A0.00
GMXAY
GENMAB A/S/S
0.5$35.74flat$0.00N/A0.00High Trading Volume
Genus logo
GENSF
Genus
0.7$69.40flat$0.00N/A0.00News Coverage
HALB
Halberd
0.0$0.04flat$0.00N/A0.00Gap Up
HAVN Life Sciences logo
HAVLF
HAVN Life Sciences
0.0$0.57flat$0.00N/A0.00Gap Up
Idorsia logo
IDRSF
Idorsia
0.5$28.40flat$0.00N/A0.00
IPATF
ImmunoPrecise Antibodies
0.5N/AN/A$0.00N/A0.00High Trading Volume
IMLFF
InMed Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Innovation Pharmaceuticals logo
IPIX
Innovation Pharmaceuticals
0.6$0.24flat$0.00N/A0.00
Kalytera Therapeutics logo
KALTF
Kalytera Therapeutics
0.6$0.04flat$0.00N/A0.00Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00flat$0.00N/A0.00Gap Up
Mesoblast logo
MEOBF
Mesoblast
0.5$1.73flat$0.00N/A0.00
MCURF
Mind Cure Health
0.0$0.27flat$0.00N/A0.00
Mind Medicine (MindMed) logo
MMEDF
Mind Medicine (MindMed)
1.1$2.24flat$0.00N/A0.00
Molecular Partners logo
MLLCF
Molecular Partners
0.5$25.19flat$0.00N/A0.00
MPSYF
MorphoSys
0.0$92.50flat$0.00N/A0.00Gap Down
NRNVF
Nordic Nanovector ASA
0.0$1.64flat$0.00N/A0.00High Trading Volume
Novozymes A/S logo
NVZMF
Novozymes A/S
0.4$65.96flat$0.00N/A0.00Gap Down
BPSR
Organicell Regenerative Medicine
0.5$0.05flat$0.00N/A0.00Gap Down
Oxurion logo
TBGNF
Oxurion
0.5$2.94flat$0.00N/A0.00
Pharnext logo
PNEXF
Pharnext
0.0$4.11flat$0.00N/A0.00
PTEO
Proteo
0.5$0.09flat$0.00N/A0.00
PROT
Proteonomix
0.5$0.01flat$0.00N/A0.00
ProtoKinetix logo
PKTX
ProtoKinetix
0.5$0.19flat$0.00N/A0.00Gap Down
PureTech Health logo
PTCHF
PureTech Health
0.0$5.71flat$0.00N/A0.00Gap Up
RCPHF
Recipharm AB (publ)
1.0$16.05flat$0.00N/A0.00High Trading Volume
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.